Its growth is attributed to the anticipated launch of seven late-stage pipeline therapies. The myasthenia gravis (MG) market ...

Late-stage pipeline products can generate demand in the MG market and with diagnosed prevalent cases, will drive growth in ...

On June 16, 2025, RemeGen Co., Ltd. ('RemeGen', stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand ...

UCB, a global biopharmaceutical company, today announced that 15 scholarships were awarded to people impacted by myasthenia gravis in the U.S. The UCB Myasthenia Gravis Scholarship™ exemplifies UCB's ...

The National Institute for Health and Care Excellence (NICE) recommended the drug not be used by the NHS due to its ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

The FDA has approved Imaavy™ (nipocalimab-aahu) for the treatment of generalized myasthenia gravis in patients aged 12 years and older who are AChR or anti-muscle-specific tyrosine kinase antibody ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

During last Monday’s meeting, the Matagorda County Commissioners Court proclaimed June as Myasthenia Gravis Awareness Month, ...

Glen Hartley is undertaking the challenge paying homage to the hobby he enjoyed with his father before he was diagnosed with ...

June is Myasthenia Gravis Awareness month. We are trying to raise awareness through various activities. One such activity is ...